Last reviewed · How we verify

NCT04240600: HEMVEF

Effect of a Hyperproteic Hyperenergetic Enteral Formula on Body Composition and VEGF in AML During Hospital Stay

Status unknown NA Last updated 3 September 2020
What this trial tests

NA trial testing Experimental group in Acute Myeloid Leukemia, Adult in 74 participants. Status unknown.

Timeline
1 December 2020
Primary endpoint
1 January 2021
1 December 2021

Quick facts

Lead sponsorHospital General de Mexico
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment74
Start date1 December 2020
Primary completion1 January 2021
Estimated completion1 December 2021
Sites2 locations across Mexico

Drugs / interventions tested

Conditions studied

Sponsor

Hospital General de Mexico

Who can join

Adults 18 to 60, any sex, with Acute Myeloid Leukemia, Adult. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized controlled clinical trial in two groups of supplementation with high protein enteral formula and a normocaloric enteral formula in two groups of 37 patients .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Experimental group

Trials testing the same drug.

Other recruiting trials for Acute Myeloid Leukemia, Adult

Currently open trials in the same condition.

Other Hospital General de Mexico trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04240600.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing